ANDA 216906, held by Somerset Theraps LLC. Brimonidine Tartrate.
As of Nov 16, 2026, ANDA 216906 (Brimonidine Tartrate), held by Somerset Theraps LLC, was first approved by FDA on Aug 9, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 9, 2024 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brimonidine Tartrate0.1% ยท solution/drops;ophthalmic | Brimonidine Tartrate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters